Okupe Oluyemi 4

4 · Hims & Hers Health, Inc. · Filed Apr 22, 2026

AI-generated summary of this filing

Updated Apr 22, 2026

Hims & Hers (HIMS) CFO Okupe Oluyemi Sells Shares, Exercises Options

What Happened

Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised stock options to acquire a total of 12,553 shares (5,553 shares at $5.01 for $27,821; 7,000 shares at $11.53 for $80,710) and sold 19,645 shares in an open-market transaction on April 20, 2026 for aggregate proceeds of about $588,615 (weighted average price $29.96). The filing reports both the option-to-share conversions (derivative activity) and the subsequent sale of shares the same day.

Key Details

Transaction date: April 20, 2026 (Form 4 filed April 22, 2026 — timely filing).
Option exercises (code M): 5,553 shares @ $5.01 (acquired $27,821); 7,000 shares @ $11.53 (acquired $80,710).
Open-market sale (code S): 19,645 shares @ weighted avg $29.96 (range $29.95–$30.005) — proceeds ≈ $588,615. The filer will provide per-price breakdown upon request (footnote F2).
Additional derivative entries at $0.00 reflect the conversion/termination of the derivative instruments upon exercise (reported as dispositions of the derivative).
Footnotes: trades were executed under a Rule 10b5-1 trading plan adopted May 21, 2025 (F1); options noted as fully vested and exercisable (F3) and subject to a 4‑year service-based vesting schedule with monthly vesting starting April 1, 2023 (F4).
Shares owned after the transaction: not specified in the provided filing details.

Context

The filing shows an exercise of options and same-day sale of shares, a common pattern when insiders exercise vested options and sell stock (often to cover exercise costs, taxes, or per a pre-established trading plan). These transactions were conducted under a 10b5-1 plan, which establishes the sales were prearranged rather than opportunistic. This report is factual and does not imply insider motivation.

Form 4

Period: 2026-04-20

Chief Financial Officer

Transactions

Exercise/Conversion
Class A Common Stock
[F1]
2026-04-20$5.01/sh+5,553$27,821→ 275,599 total
Exercise/Conversion
Class A Common Stock
[F1]
2026-04-20$11.53/sh+7,000$80,710→ 282,599 total
Sale
Class A Common Stock
[F1][F2]
2026-04-20$29.96/sh−19,645$588,615→ 262,954 total
Exercise/Conversion
Stock Option (right to buy)
[F1][F3]
2026-04-20−5,553→ 123,850 total
Exercise: $5.01Exp: 2032-02-23→ Class A Common Stock (5,553 underlying)
Exercise/Conversion
Stock Option (right to buy)
[F1][F4]
2026-04-20−7,000→ 35,996 total
Exercise: $11.53Exp: 2033-03-01→ Class A Common Stock (7,000 underlying)

Holdings

Footnotes (4)

[F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
[F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $29.95 - $30.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]The stock options are fully vested and exercisable.
[F4]The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.

Signature

/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe|2026-04-22

1 file